Market Analysis and Insights: Global In Vitro Gene Therapy Market
The global In Vitro Gene Therapy market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for In Vitro Gene Therapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for In Vitro Gene Therapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for In Vitro Gene Therapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of In Vitro Gene Therapy include Orchard Therapeutics, Kolon Pharma, bluebird bio, Novartis, GILD (Kite Pharma), Bristol Myers Squibb and JW Therapeutics, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for In Vitro Gene Therapy market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of In Vitro Gene Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for In Vitro Gene Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the In Vitro Gene Therapy revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global In Vitro Gene Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for In Vitro Gene Therapy revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Orchard Therapeutics, Kolon Pharma, bluebird bio, Novartis, GILD (Kite Pharma), Bristol Myers Squibb and JW Therapeutics, etc.
By Company
Orchard Therapeutics
Kolon Pharma
bluebird bio
Novartis
GILD (Kite Pharma)
Bristol Myers Squibb
JW Therapeutics
Segment by Type
CAR-T
CRISPR
Segment by Application
Hospital
Specialty Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of In Vitro Gene Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Gene Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In Vitro Gene Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Gene Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 CAR-T
1.2.3 CRISPR
1.3 Market by Application
1.3.1 Global In Vitro Gene Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Gene Therapy Market Perspective (2018-2029)
2.2 Global In Vitro Gene Therapy Growth Trends by Region
2.2.1 In Vitro Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 In Vitro Gene Therapy Historic Market Size by Region (2018-2023)
2.2.3 In Vitro Gene Therapy Forecasted Market Size by Region (2024-2029)
2.3 In Vitro Gene Therapy Market Dynamics
2.3.1 In Vitro Gene Therapy Industry Trends
2.3.2 In Vitro Gene Therapy Market Drivers
2.3.3 In Vitro Gene Therapy Market Challenges
2.3.4 In Vitro Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue In Vitro Gene Therapy by Players
3.1.1 Global In Vitro Gene Therapy Revenue by Players (2018-2023)
3.1.2 Global In Vitro Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global In Vitro Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of In Vitro Gene Therapy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global In Vitro Gene Therapy Market Concentration Ratio
3.4.1 Global In Vitro Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Gene Therapy Revenue in 2022
3.5 Global Key Players of In Vitro Gene Therapy Head office and Area Served
3.6 Global Key Players of In Vitro Gene Therapy, Product and Application
3.7 Global Key Players of In Vitro Gene Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Gene Therapy Breakdown Data by Type
4.1 Global In Vitro Gene Therapy Historic Market Size by Type (2018-2023)
4.2 Global In Vitro Gene Therapy Forecasted Market Size by Type (2024-2029)
5 In Vitro Gene Therapy Breakdown Data by Application
5.1 Global In Vitro Gene Therapy Historic Market Size by Application (2018-2023)
5.2 Global In Vitro Gene Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America In Vitro Gene Therapy Market Size (2018-2029)
6.2 North America In Vitro Gene Therapy Market Size by Type
6.2.1 North America In Vitro Gene Therapy Market Size by Type (2018-2023)
6.2.2 North America In Vitro Gene Therapy Market Size by Type (2024-2029)
6.2.3 North America In Vitro Gene Therapy Market Share by Type (2018-2029)
6.3 North America In Vitro Gene Therapy Market Size by Application
6.3.1 North America In Vitro Gene Therapy Market Size by Application (2018-2023)
6.3.2 North America In Vitro Gene Therapy Market Size by Application (2024-2029)
6.3.3 North America In Vitro Gene Therapy Market Share by Application (2018-2029)
6.4 North America In Vitro Gene Therapy Market Size by Country
6.4.1 North America In Vitro Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America In Vitro Gene Therapy Market Size by Country (2018-2023)
6.4.3 North America In Vitro Gene Therapy Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe In Vitro Gene Therapy Market Size (2018-2029)
7.2 Europe In Vitro Gene Therapy Market Size by Type
7.2.1 Europe In Vitro Gene Therapy Market Size by Type (2018-2023)
7.2.2 Europe In Vitro Gene Therapy Market Size by Type (2024-2029)
7.2.3 Europe In Vitro Gene Therapy Market Share by Type (2018-2029)
7.3 Europe In Vitro Gene Therapy Market Size by Application
7.3.1 Europe In Vitro Gene Therapy Market Size by Application (2018-2023)
7.3.2 Europe In Vitro Gene Therapy Market Size by Application (2024-2029)
7.3.3 Europe In Vitro Gene Therapy Market Share by Application (2018-2029)
7.4 Europe In Vitro Gene Therapy Market Size by Country
7.4.1 Europe In Vitro Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe In Vitro Gene Therapy Market Size by Country (2018-2023)
7.4.3 Europe In Vitro Gene Therapy Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China In Vitro Gene Therapy Market Size (2018-2029)
8.2 China In Vitro Gene Therapy Market Size by Type
8.2.1 China In Vitro Gene Therapy Market Size by Type (2018-2023)
8.2.2 China In Vitro Gene Therapy Market Size by Type (2024-2029)
8.2.3 China In Vitro Gene Therapy Market Share by Type (2018-2029)
8.3 China In Vitro Gene Therapy Market Size by Application
8.3.1 China In Vitro Gene Therapy Market Size by Application (2018-2023)
8.3.2 China In Vitro Gene Therapy Market Size by Application (2024-2029)
8.3.3 China In Vitro Gene Therapy Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia In Vitro Gene Therapy Market Size (2018-2029)
9.2 Asia In Vitro Gene Therapy Market Size by Type
9.2.1 Asia In Vitro Gene Therapy Market Size by Type (2018-2023)
9.2.2 Asia In Vitro Gene Therapy Market Size by Type (2024-2029)
9.2.3 Asia In Vitro Gene Therapy Market Share by Type (2018-2029)
9.3 Asia In Vitro Gene Therapy Market Size by Application
9.3.1 Asia In Vitro Gene Therapy Market Size by Application (2018-2023)
9.3.2 Asia In Vitro Gene Therapy Market Size by Application (2024-2029)
9.3.3 Asia In Vitro Gene Therapy Market Share by Application (2018-2029)
9.4 Asia In Vitro Gene Therapy Market Size by Region
9.4.1 Asia In Vitro Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia In Vitro Gene Therapy Market Size by Region (2018-2023)
9.4.3 Asia In Vitro Gene Therapy Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America In Vitro Gene Therapy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America In Vitro Gene Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America In Vitro Gene Therapy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America In Vitro Gene Therapy Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America In Vitro Gene Therapy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America In Vitro Gene Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America In Vitro Gene Therapy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America In Vitro Gene Therapy Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America In Vitro Gene Therapy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America In Vitro Gene Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America In Vitro Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America In Vitro Gene Therapy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America In Vitro Gene Therapy Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Orchard Therapeutics
11.1.1 Orchard Therapeutics Company Details
11.1.2 Orchard Therapeutics Business Overview
11.1.3 Orchard Therapeutics In Vitro Gene Therapy Introduction
11.1.4 Orchard Therapeutics Revenue in In Vitro Gene Therapy Business (2018-2023)
11.1.5 Orchard Therapeutics Recent Developments
11.2 Kolon Pharma
11.2.1 Kolon Pharma Company Details
11.2.2 Kolon Pharma Business Overview
11.2.3 Kolon Pharma In Vitro Gene Therapy Introduction
11.2.4 Kolon Pharma Revenue in In Vitro Gene Therapy Business (2018-2023)
11.2.5 Kolon Pharma Recent Developments
11.3 bluebird bio
11.3.1 bluebird bio Company Details
11.3.2 bluebird bio Business Overview
11.3.3 bluebird bio In Vitro Gene Therapy Introduction
11.3.4 bluebird bio Revenue in In Vitro Gene Therapy Business (2018-2023)
11.3.5 bluebird bio Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis In Vitro Gene Therapy Introduction
11.4.4 Novartis Revenue in In Vitro Gene Therapy Business (2018-2023)
11.4.5 Novartis Recent Developments
11.5 GILD (Kite Pharma)
11.5.1 GILD (Kite Pharma) Company Details
11.5.2 GILD (Kite Pharma) Business Overview
11.5.3 GILD (Kite Pharma) In Vitro Gene Therapy Introduction
11.5.4 GILD (Kite Pharma) Revenue in In Vitro Gene Therapy Business (2018-2023)
11.5.5 GILD (Kite Pharma) Recent Developments
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Details
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb In Vitro Gene Therapy Introduction
11.6.4 Bristol Myers Squibb Revenue in In Vitro Gene Therapy Business (2018-2023)
11.6.5 Bristol Myers Squibb Recent Developments
11.7 JW Therapeutics
11.7.1 JW Therapeutics Company Details
11.7.2 JW Therapeutics Business Overview
11.7.3 JW Therapeutics In Vitro Gene Therapy Introduction
11.7.4 JW Therapeutics Revenue in In Vitro Gene Therapy Business (2018-2023)
11.7.5 JW Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Orchard Therapeutics
Kolon Pharma
bluebird bio
Novartis
GILD (Kite Pharma)
Bristol Myers Squibb
JW Therapeutics
*If Applicable.